Robust evidence has showed a close association between CMV cell-mediated immunity, especially CMV-specific CD4+ and CD8+ T lymphocytes, and the risk of developing a CMV infection in different transplant settings [25,26]. This evidence concerns the gene CD4 and cytomegalovirus infection.